We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Hemostasis Analyzer Provides Clotting, Chromogenic, and Immunoturbidimetric Testing Capabilities

By Labmedica staff writers
Posted on 06 Aug 2008
Print article
Image: The ACL TOP hemostasis analyzer (Photo courtesy of Beckman Coulter).
Image: The ACL TOP hemostasis analyzer (Photo courtesy of Beckman Coulter).
A powerful hemostasis analyzer has been developed for mid-high volume laboratories.

Called the ACL TOP 500 CTS (closed tube sampling) hemostasis analyzer, it is the newest addition to the family of ACL TOP systems, and was released by Beckman Coulter (Fullerton, CA, USA) in partnership with Instrument Laboratory (IL; Huntington Beach, CA, USA).

The hemostasis analyzer offers 24-hour, 7-day continuous operation without workflow interruption. It can hold 800 cuvettes and delivers up to 240 tests per hour. Cap piercing is automated and results arrive quickly, with prothrombin time (PT) reported in three minutes or less.

The analyzer provides clotting, chromogenic and immunoturbidimetric testing capabilities with a complete menu of routine and specialty assays. Its LED-based clot detection allows it to read clot-based assays at 671 nm, which helps minimize the effects of most preanalytic variables. The interface is user-friendly and operators need only a minimal amount of training.

The TOP 500 CTS is a compact, powerful analyzer that helps labs maximize labor resources, reduce turnaround time, and improve patient care.

Beckman Coulter provides a wide range of coagulation analyzers that deliver consistent, quality results with minimal maintenance. The wide selection of specialty assays and reagents are also designed to maximize the labs' capabilities. The company also offers service to enable the labs to operate at peak efficiency.


Related Links:
Beckman Coulter
Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Mumps Virus Test
ZEUS ELISA Mumps IgG Test System
New
Respiratory Bacterial Panel
Real Respiratory Bacterial Panel 2

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.